Learn More
BACKGROUND Alternative methods for influenza vaccine production are needed to ensure adequate supplies. METHODS Healthy adults 50-64 years were assigned randomly to receive one intramuscular(More)
Background Seasonal influenza vaccines are transitioning to quadrivalent formulations including the hemagglutinins of influenza A subtypes H1N1 and H3N2 and B lineages Yamagata and Victoria. (More)